Invenomic Capital Management LP

Q4 2025 13F-HR Holdings

Location
Boston, MA
Holdings as of
12/31/2025
Date filed
2/17/2026
Form type
13F-HR
Num holdings
147
Total value ($000)
$2,148,430
Net value change ($000)
+82,622 (4.0%)
New positions
28
Sold out positions
25
Turnover %
20.0%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q3 2025
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
AKAM 20,782 55.0%
OMC 20,497 125.8%
FISV 19,296 NEW
OC 18,327 NEW
INGR 16,691 NEW
MOS 16,339 NEW
VTRS 16,050 29.9%
CENT 13,749 NEW
KRNT 13,747 216.3%
RYZ 12,410 307.8%
Top Reduces (Value $000, Stocks/ETFs)
HAE -24,288 -100.0%
BKH -19,608 -100.0%
SEE -15,493 -100.0%
VZ -14,990 -63.3%
UHS -14,979 -100.0%
GOLD -13,445 -100.0%
KHC -12,978 -100.0%
JAMF -12,888 -100.0%
IQV -10,874 -100.0%
LYFT -10,786 -34.7%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 77,299 (3.6% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type